EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-Reported Improvement for Chronic Rhinosinusitis Major Symptoms in Patients Treated with Omalizumab

Shaun J. Kilty, Corliss Best, Stephanie Santucci, Andrea Lasso, William Yang

Journal of Respiration · 2020

DOI: 10.3390/jor1010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Respiration, 2020. Verfasst von Shaun J. Kilty und 4 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the clinical effect of omalizumab therapy on the symptoms of patients with chronic rhinosinusitis (CRS).

Methods

This cross-sectional study evaluated CRS major symptom improvement in patients with CRS on omalizumab therapy and patients who met omalizumab therapy indications, but could not access coverage for omalizumab. Changes in overall chronic rhinosinusitis symptom burden and each of the major symptoms of CRS were rated on a 10 cm visual analogue scale (VAS). The Mann–Whitney test was used to compare the symptom improvement between groups.

Results

Omalizumab therapy provided a mean overall symptom improvement of 69.5% (individual symptom improvement: facial pain 78.5%, nasal obstruction 69.8%, rhinorrhea 56.2%, and olfaction 55.8%). For the control group, mean overall symptom improvement since omalizumab screening was 16.8% (individual symptom improvement: rhinorrhea 16.4%, nasal obstruction 15.3%, no improvement in facial pain or olfaction). Overall, and for each major symptom, improvement was significantly greater for omalizumab treated patients (p < 0.05).

Conclusion

Omalizumab treatment provided significant improvement in every major clinical symptom of CRS in the treated cohort of patients with recalcitrant CRS, in comparison to the control cohort. A well-designed randomized clinical trial is needed to further assess the efficacy and safety of omalizumab treatment for CRS.

Zitieren

APA

Kilty, S. J., Best, C., Santucci, S., Lasso, A., & Yang, W. (2020). Self-Reported Improvement for Chronic Rhinosinusitis Major Symptoms in Patients Treated with Omalizumab. Journal of Respiration. https://doi.org/10.3390/jor1010001

Vancouver

Kilty SJ, Best C, Santucci S, Lasso A, Yang W. Self-Reported Improvement for Chronic Rhinosinusitis Major Symptoms in Patients Treated with Omalizumab. Journal of Respiration. 2020. doi:10.3390/jor1010001

BibTeX
@article{Kilty2020,
  author = {Kilty, Shaun J. and Best, Corliss and Santucci, Stephanie and Lasso, Andrea and Yang, William},
  title = {Self-Reported Improvement for Chronic Rhinosinusitis Major Symptoms in Patients Treated with Omalizumab},
  journal = {Journal of Respiration},
  year = {2020},
  doi = {10.3390/jor1010001}
}
Kostenlos starten →